Thomas Mahoney

Tom Mahoney is a Senior Managing Director at Tangent Capital Partners, LLC, a FINRA- and SIPC-member broker-dealer that operates as a placement agent and advisory firm at the intersection of private capital and modern markets. He brings more than 30 years of experience in the alternative-investments industry and is credited with raising over $7 billion for hedge funds, private equity funds, and corporate private-equity financings since 1985.

His Wall Street career spans several major institutions. He began in international M&A at Dillon Read, then founded PaineWebber's Private Equity Group. During a roughly ten-year tenure at Merrill Lynch he created the firm's global hedge-fund capital-raising business and built an industry-leading preferred-stock capital-markets franchise. He subsequently led Deutsche Bank's technology private-equity financing business. He later served as Chief Operating Officer, Chief Risk Officer, and Head of Alternative Investments at Gabelli & Partners (a subsidiary of Gabelli Asset Management), and as a Managing Director with Compass Advisers Group, LLC.

Mahoney earned an A.B. in chemistry from Harvard College and an M.B.A. from the Wharton School at the University of Pennsylvania. He holds Series 7, 24, 63, and 79 FINRA securities licenses (FINRA CRD individual #843330).

Beyond finance, he is a member of the Council on Foreign Relations and serves on the Board of Overseers of Mount Auburn Hospital, a Harvard Medical School affiliate; he has also previously held a board role connected to the New York City Opera.

• Operates as a capital-formation and placement professional within alternative and structured investments rather than as a personal seed-stage angel.
• Decades of focus on hedge funds, private equity funds, technology private equity, and corporate private financings — raising institutional capital and structuring strategy-diversified portfolios.
• Tangent Capital's stated "big idea" is to "increase client success rates – and lower costs – by improving the underlying private investment and capital formation processes," positioning around new private-market distribution networks, institutional adoption of alternative sourcing, product innovation for affluent investors, and emerging regulated markets for previously illiquid securities.
• The firm's team is built from former securities lawyers, fund managers, allocators, and technology executives — a profile oriented toward private-fund structuring and distribution, not check-writing into startups.